Monoclonal Antibody Infusions

IV and subcutaneous monoclonal antibody infusions are now available to qualifying patients on an outpatient basis.

WHAT ARE MONOCLONAL ANTIBODIES?

This Covid-19 treatment uses antibodies that are similar to the ones your body would naturally make in response to infection. However, monoclonal antibodies are produced in a laboratory and are designed to recognize a specific component of this virus — the spike protein on its outer shell. By targeting the spike protein, these specific antibodies interfere with the virus’ ability to attach and gain entry into human cells.

HOW DOES IT HELP?

REDUCING HOSPITAL ADMISSIONS​

Monoclonal Antibody infusions help reduce hospital admissions by 70%

LOWERING VIRAL LOADS

Giving your immune system a leg up to mount its own response

LOWERING VIRAL LOADS

LESSENING SEVERITY  OF SYMPTOMS

Who Qualifies?

  • Someone who has received a positive Covid-19 test and has not been admitted to the hospital
  • Someone over the age of 12 Patients who have certain health
  • conditions that put them at high risk for severe complications

STAY TUNED FOR MORE DETAILS ON THIS EXCITING NEW SERVICE

PLEASE BE AWARE THERE MAY BE CHANGES TO OUR URGENT CARE HOURS AS WE ADAPT TO ACCOMMODATE THIS MUCH NEEDED NEW THERAPY

Similar Posts